Our Senior Scientist, Kawanobe Ph.D., the first author, published in Nucleic Acid Therapeutics collaborative research with Axcelead Drug Discovery Partners, Inc. using XNAs technology. 2025/03/27 Notice Read
Notice of Conclusion of License Agreement with Summit Pharmaceuticals International Corporation for the Manufacture and Sale of Artificial Modified Nucleic Acid Amidite 2024/12/17 Notice Read
Result of the Ex-post evaluation of the Spinal Cord Injury (SCI) Program of Cyclic Innovation for Clinical Empowerment (CiCLE) supported by Japan Agency for Medical Research and Development (AMED) 2024/11/28 Notice Read
We have been selected for the “Research and Development Program for Innovative Biologics” in 2024. 2024/09/12 Notice Read
Notice of a collaboration agreement with Renascience, Inc. to develop antisense oligonucleotides for treating hereditary neurological intractable diseases 2024/06/24 Notice Read
